Browsing by Author "Ahirirwe, Sherry R."

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Ebola disease outbreak caused by the Sudan virus in Uganda, 2022: a descriptive epidemiological study
    (The Lancet Global Health, 2024-10-29) Kabami, Zainah; Ario, Alex R.; Ninsiima, Mackline; Ahirirwe, Sherry R.; Atwine, Diana; Ocero, Jane R Aceng; Nanyunja, Miriam; Ndyabakira, Alex; Zavuga, Robert; Kiggundu, Thomas
    Uganda has had seven Ebola disease outbreaks, between 2000 and 2022. On Sept 20, 2022, the Ministry of Health declared a Sudan virus disease outbreak in Mubende District, Central Uganda. We describe the epidemiological characteristics and transmission dynamics.
  • Thumbnail Image
    Item
    Readiness of health facilities to manage individuals infected with COVID-19, Uganda, June 2021
    (BMC Health Services Research, 2023-05-04) Mwine, Patience 1*,1, 1, 1,; Ahirirwe, Sherry R.; Nansikombi, Hilda T.; Senyange, Shaban; Monje, Fred; Kyamwine, Irene B.; Ario, Alex R.; Harris, Julie R.
    The COVID-19 pandemic overwhelmed the capacity of health facilities globally, emphasizing the need for readiness to respond to rapid increases in cases. The first wave of COVID-19 in Uganda peaked in late 2020 and demonstrated challenges with facility readiness to manage cases. The second wave began in May 2021. In June 2021, we assessed the readiness of health facilities in Uganda to manage the second wave of COVID-19.
  • Thumbnail Image
    Item
    Time to care and factors influencing appropriate Sudan virus disease care among case patients in Uganda, September to November 2022
    (International Journal of Infectious Diseases, 2024-08) Akunzirwe, Rebecca; Simbwa, Brenda N.; Ahirirwe, Sherry R.; Namubiru, Saudah K.; Harris, Julie R.
    Early isolation and care for Ebola disease patients at Ebola Treatment Units (ETU) curb outbreak spread. We evaluated time to ETU entry and associated factors during the 2022 Sudan virus disease (SVD) outbreak in Uganda. We included persons with RT-PCR-confirmed SVD with onset September 20-November 30, 2022. We categorized days from symptom onset to ETU entry (“delays”) as short (≤2), moderate (3-5), and long (≥6); the latter two were “delayed isolation.” We categorized symptom onset timing as “earlier” or “later,” using October 15 as a cut-off. We assessed demographics, symptom onset timing, and awareness of contact status as predictors for delayed isolation. We explored reasons for early vs late isolation using key informant interviews.